drugset / Trial / NCT06896747

Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study

NCT06896747

Phase 1/2 Recruiting 90 enrolled Tang-Du Hospital Xi'an Jiaotong University · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to evaluate if engineered mechanically umbilical cord-derived stem cell exosomes, or conventional umbilical cord -derived stem cell exosomes, can improve endometrial thickness in women with thin endometrium. The main questions it aims to answer are: Can exosomes delivered via subendometrial injection improve endometrial thickness or clinical pregnancy rates compared to PRP (platelet-rich plasma)? Are there significant differences in endometrial thickness between the two treatment groups? Researchers will compare the intervention groups, which one group receives mechanical exosomes and the other receives conventional esosomes via subendometrial injection, to the control group, which receives PRP via the same methods, to see if exosomes provide superior therapeutic effects. Participants will: Receive either mechanical exosomesor or conventional esosomes or PRP through subendometrial injection. Be monitored for changes in endometrial parameters.

Timeline

Start
2025-02-21
Primary completion
2025-06-12
Completion
2027-03-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject ME-UCMSC-Exo Unknown 1 ml Other
Subject ME-UCMSC-Exo Unknown 1.5 ml Other
Comparator Platelet Rich Plasma Other / unclassified 1 ml Other
Comparator Platelet Rich Plasma Other / unclassified 1.5 ml Other
Subject UCMSC-Exo Other / unclassified 1 ml Other
Subject UCMSC-Exo Other / unclassified 1.5 ml Other